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1	Introduction
Iron	is	a	key	trace	element,	involved	in	different	processes	of	metabolism	such	as	respiration,	energy	production,	DNA	synthesis	and	cell	proliferation.	However,	given	its	capacity	for	changing	valency,	it	also
has	potential	for	toxicity	at	excessive	levels.	Consequently,	a	tight	regulation	of	absorption	and	excretion	has	evolved.
Many	studies	have	examined	the	way	other	nutrients	and	micronutrients	interact	with	iron	metabolism.	These	interactions	can	be	both	direct	and	indirect.	For	example,	vitamin	C	or	cysteine	and	histidine	can
bind	iron	atoms,	increasing	bioavailability	and	increasing	iron	absorption	[1–3].	Alternatively,	copper	deficiency	can	negatively	impact	iron	flux	from	the	liver	by	decreasing	the	expression	of	ceruloplasmin,	required
for	 iron	 incorporation	 into	 transferrin	 [4].	 Nutrients	 that	 alter	 expression	 of	 some	 of	 the	 iron	 regulatory	 pathways	 can	 also	modify	 iron	metabolism	 [5].	 These	 compounds	 have	 proved	 particularly	 valuable	 in
elucidating	the	regulation	of	iron.
Dietary	iron	is	found	in	two	forms;	haem	iron	and	non-haem	(inorganic)	iron.	These	two	forms	of	iron	have	separate	absorption	mechanisms	across	the	gut	[6–8].	Haem	iron	is	transported	either	by	a	haem
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Abstract
Iron	(Fe)	metabolism	is	modified	by	many	nutritional	factors.	Amino	acids	(AA)	play	a	central	role	in	various	biological	processes,	such	as	protein	synthesis	and	energy	supply.	However,	the	influence	of
AA	status	on	iron	metabolism	has	not	been	investigated.	Here,	we	test	whether	AA	alters	iron	metabolism	in	an	intestinal	cell	model.	Both	Fe	uptake	and	transfer	across	the	cell	monolayer	were	significantly
increased	by	non-essential	AA	deficiency	(both	p	<	0.001)	while	only	Fe	transfer	was	increased	by	essential	AA	deficiency	(p	<	0.0001).	Both	essential	and	non-essential	AA	deficiency	decreased	DMT1	(±IRE)
exon1A	mRNA	expression	(respectively	p	=	0.0007	and	p	=	0.006)	and	increased	expression	of	ferritin	heavy	chain.	DMT1	+	IRE	(also	expressing	exon1A	or	1B)	mRNA	levels	were	decreased	by	essential	AA
deficiency	(p	=	0.012).	The	mRNA	levels	of	total	DMT1	were	also	decreased	by	essential,	but	not	non-essential,	AA	deficiency	(p	=	0.006).	Hepcidin	levels	were	increased	significantly	by	non-essential	amino
acid	deprivation	(p	=	0.047).	Protein	 levels	of	 ferroportin	and/or	ferritin	heavy	chain	were	not	altered	by	AA	deficiency,	suggesting	that	they	had	no	effect	on	Fe	efflux	or	storage	 in	the	cell,	 though	iron
content	of	 ferritin	could	be	 increased.	Our	data	demonstrate,	 for	 the	 first	 time,	 that	AA	status	affects	 iron	transport	and	the	expression	of	genes	related	to	 iron	metabolism	in	Caco-2	cells,	although	the
changes	observed	are	not	sufficient	to	explain	the	alteration	in	iron	transport.	We	hypothesise	that	the	effect	on	Fe	transfer	is	mediated	through	an	increased	movement	across	the	cell	layer,	rather	than
transfer	across	the	cell	membranes.
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importer,	possibly	HCP1	(haem	carrier	protein	1,	SLC46A1),	though	it	may	primarily	be	a	folate	transporter	[9]	[,10],	or	by	a	receptor-mediated	endocytotic	pathway	[11].	Once	internalized,	haem	iron	is	released	as
ferrous	iron	by	hemoxygenase,	mainly	hemoxygenase	1	(HOX1)	[12],	and	then	enters	the	same	pathways	as	non-haem	iron	[13].	Non-haem	iron	needs	to	be	first	reduced	from	ferric	iron	(Fe3+)	to	ferrous	iron	(Fe2+)	by
Dcytb	(duodenal	cytochrome	B)	on	the	gut	apical	cell	membrane.	Ferrous	iron	is	then	transported	into	the	enterocytes	through	DMT1	(divalent	metal	transporter	1,	or	SLC11A2).	In	the	enterocyte,	iron	becomes	part
of	the	labile	iron	pool	[14],	and/or	becomes	bound	to	the	storage	protein	ferritin,	or	is	released	into	the	blood	stream	via	ferroportin,	a	transmembrane	transport	protein	[15].	The	iron	is	exported	as	Fe2+,	and	is	re-
oxidised	by	hephaestin	prior	to	incorporation	into	transferrin.
Iron	 absorption	 is	 regulated	by	 a	hormone	 called	hepcidin	 [16–18].	Hepcidin	 is	 secreted	 by	 the	 liver	 and	 binds	 to	 ferroportin	 in	 target	 cells,	 inducing	 internalization	 and	 degradation	 of	 ferroportin	 [19].
Hepcidin	is	not	only	regulated	by	iron	bioavailability	and	hepatic	iron	storage	but	also	by	other	factors	including	erythropoietic	activity,	hypoxia	and	inflammatory	or	infectious	disease.
Four	isoforms	of	DMT1	have	been	identified	[20].	The	predominant	isoform	carries	an	iron	regulator	element	(IRE)	sequence	and	an	exon	1A	sequence	[21].	This	isoform	(+IRE/exon1A)	has	the	highest	iron
uptake	rate	and	is	therefore	considered	as	the	most	active	isoform.	DMT1(+IRE/exon1A)	is	present	mostly	at	the	apical	membrane	of	enterocytes.	An	intermediary	isoform	exhibits	the	IRE	element	and	an	exon1	B
sequence.	 This	 form	 (+IRE/exon1B)	 is	mildly	 active	 and	 is	 found	mostly	 in	 blood	 cells	 [22].	 The	 presence	 of	 either	 exon1A	 or	 exon	 1	B	 is	 thought	 to	 have	 a	 link	with	 the	 localization	 of	 the	DMT1	 on	 different
membranes.	The	 two	other	 isoforms	have	no	 IRE	sequence	and	can	contain	either	exon1A	 (-IRE/exon1A)	or	exon1	B	(-IRE/exon1B).	They	are	 thought	 to	be	 localized	on	 the	membrane	of	endosomes	 [23,24].	 The
isoforms	of	DMT1	exhibiting	an	IRE	sequence	are	regulated	in	the	same	way	as	TfR1	and	their	mRNA	sequences	are	stabilized	by	IRP	binding	[24].	This	means	that	in	presence	of	high	concentration	of	iron,	DMT1
mRNA	is	degraded,	while	in	iron	deficiency,	translation	of	DMT1	mRNA	translation	is	increased.
Amino	acid	absorption	across	the	gut	is	also	very	tightly	regulated	by	a	variety	of	different	signaling	pathways,	the	most	important	one	being	mTOR.	Depletion	of	amino	acids	alters	significantly	mTOR	and
GCN2/elF2α	pathway,	both	responsible	for	major	protein	synthesis	changes	and	shut-down	[25,26]	The	inhibition	of	mTOR	decreases	phosphorylation	of	different	actors	involved	in	ribosome	recruitment	(4E-BPS	and
downstream	targets)	and	elongation	(S6Ks	and	downstream	targets).	The	activation	of	GCN2	leads	to	the	inhibition	of	an	elongation	factor	required	for	protein	synthesis	(elF2B)	while	up-regulation	of	ATF4	and	ATF2
by	elF2α	increase	the	transcription	of	targeted	genes	via	binding	to	an	Amino	Acid	Regulatory	Element	(AARE).	We	have	shown	that	iron	is	intimately	involved	in	this	process,	and	deficiency	results	in	changing	of
activity	of	phosphorylation	pathways	[27].	Despite	the	fact	that	they	share	regulatory	signaling	pathways,	such	as	mTOR,	the	possibility	of	an	inverse	relationship	between	amino	acid	metabolism	and	iron	metabolism
−	that	changing	status	of	amino	acids	alters	iron	metabolism	−	has	never	been	studied.	Given	the	central	role	they	both	play	in	metabolism,	this	is	perhaps	surprising.	Amino	acids	are	categorized	as	essential	or	non-
essential	according	to	their	ability	to	be	synthesized	by	human	cells.	We	tested	the	hypothesis	that	altering	their	levels	will,	in	turn,	affect	iron	metabolism	in	gut	cells.
2	Material	and	methods
2.1	Caco-2	cell	line
The	Caco-2	line	TC-7	strain	was	kindly	provided	by	the	National	Institute	of	Food	and	Nutrition	(INRAN),	Rome,	Italy	(RRID:CVCL_0233).	The	protocols	used	for	maintenance	and	experiments	are	derived	from	the	European
project	EU	FP6	Project	“LIINTOP”,	which	has	been	developed	as	a	gold	standard	approach	and	to	give	the	most	reliable	results	[28].	The	cells	were	maintained	in	56.7	cm2	plates	(Nunclon,	Nunc,	cat	n°172958)	in	DMEM	(Dulbecco’s
Modified	Eagle	Medium,	4.5	g/L	Glucose,	11	g/L	sodium	pyruvate,	no	L-Glutamine,	Gibco	Life	Technologies,	Ref	21969-035)	supplemented	with	10%	FCS	(Fetal	Calf	Serum,	heat	 inactivated,	Hyclone	Laboratories,	 Inc.),	penicillin
(100kU/L),	streptomycin	(100	g/L)	 (Pen	Step,	Gibco	Life	Technologies,	cat	n°10378-06),	glutamine	(4	mM)	(100x,	Gibco,	Life	Technologies,	cat	n°25030-024)	and	1%	non-essential	amino	acid	solution	 (Sigma	Aldrich,	M7145).	This
DMEM	preparation	is	referred	as	‘complete	DMEM’	below.
2.2	Passaging	and	viability
Cells	were	passaged	routinely	at	4.5	×	103	cells/cm2	for	normal	line	maintenance,	allowing	them	to	grow	to	approximately	50%	confluence	between	passages	in	a	humidified	incubator	at	37	°C	under	a	10%	CO2	atmosphere
[28,29].	Cells	were	used	for	experiments	between	passage	10	and	passage	33	as	recommended	[30,31].
For	each	 transport	experiment,	cells	were	seeded	at	3	×	105	cells/cm2	on	1.12	cm2	 inserts	 (SnapwellTM	permeable	 support,	 0.4	 μm	polycarbonate	membrane,	Corning	Star,	 ref	 3407).	 After	 one	week,	 the	 apical	medium
routinely	used	for	maintenance	was	DMEM	without	FCS,	while	complete	DMEM	was	still	used	as	basolateral	medium	[28,32].	The	cells	were	considered	as	differentiated	and	usable	for	experiments	when	the	transepithelial	electric
resistance	(TEER,	Ω.cm2)	reached	240	Ω.	cm2)	reached	240	Ω	cm2,	which	takes	about	21	days	[33].
2.3	Amino	acid	depleted	media
The	AA	deprived	media	were	prepared	using	HBSS	(Hank’s	balanced	Salt	Solution),	1	mM	sodium	pyruvate,	1	x	vitamin	solution	(Sigma	Aldrich	x100,	M6895),	270	USP	units/L	insulin	(Human	recombinant,	zinc	solution,	Gibco
Life	technologies,	cat	n°12585-014),	5.5	mg/L	transferrin	(Human,	T8158,	Sigma	Aldrich),	0.029	μM	sodium	selenite,	100	μg/mL	streptomycin,	100	kU/L	of	penicillin	(Pen	Strep,	see	above),	4	mM	L-Glutamine.	Non	Essential	Amino
Acids	Solution	and	Amino	Acids	Solution	 (M5550)	were	used	at	different	concentrations	 for	amino	acid	deprivation	of	 the	cells	 (Table	1).	When	 the	concentrations	of	essential	amino	acids	were	studied,	 the	concentration	of	non-
essential	amino	acids	was	kept	constant	at	100%	and	vice	versa.	All	media	were	adjusted	to	a	pH	of	7.4.
Table	1	Final	concentrations	(μmol/L)	of	amino	acids	in	the	control	medium	(100%	AA),	essential	amino	acid	depleted	(0%	EAA)	and	non-essential	amino	acid	depleted	(0%	NEAA)	media.	Glutamine	is	added
separately	to	control	and	essential	amino	acid	depleted	media,	and	is	considered	as	a	non-essential	amino	acid.
alt-text:	Table	1
100%	AA	(μM) 0%	EAA	(μM) 0%	NEAA	(μM)
ESS	and	COND	ESS	(M5550)
LL-Arginine 126.4 0.0 126.4
L-CYSTEINE∘L-cysteine·2HCl 31.3 0.0 31.3
L-HISTIDINE∘HCL∘L-Histidine·HCl·H2O 42.0 0.0 42.0
LL-Isoleucine 52.5 0.0 52.5
LL-Leucine 52.4 0.0 52.4
L-LYSINE∘L-Lysine·HCl 72.5 0.0 72.5
LL-Methionine 15.1 0.0 15.1
LL-Phenylalanine 33.0 0.0 33.0
LL-Threonine 47.6 0.0 47.6
L-TRYPTOPHAN10.20.010.2LL-Tryptophan 10.2 0.0 10.2
L-Tyrosine 36.0 0.0 36.0
LL-Valine 46.8 0.0 46.8
NON	ESS	(M7145)
LL-Alanine 8.9 8.9 0.0
L-ASPARAGINE∘L-Asparagine·H2O 15.0 15.0 0.0
LL-Aspartic	Acid 13.3 13.3 0.0
LL-Glutamic	Acid 14.7 14.7 0.0
Glycine 7.5 7.5 0.0
LL-Proline 11.5 11.5 0.0
LL-Serine 10.5 10.5 0.0
LL-Glutamine 584.6 584.6 0.0
2.4	59Fe	transepithelial	transport
After	differentiation,	cells	were	incubated	overnight	(17	h)	in	media	containing	different	concentrations	(0-–100%	control)	of	either	essential	or	non-essential	amino	acids,	The	following	morning,	the	cells	were	washed	three
times	in	PBS	(Phosphate	Buffered	Saline)	prior	to	addition	of	the	experimental	media.
Two	buffers	were	used	to	conduct	the	transport	experiments.	The	apical	buffer	consisted	of	20	mM	HEPES,	5	mM	Glucose,	1	mM	Phenol	Red	in	1xBSS	(pH7.4).	The	basolateral	buffer	was	made	of	20	mM	HEPES,	5	mM	Glucose
in	1xBSS	(pH7.4).	For	all	these	experiments,	6	μCi/mL	of	59Fe	was	added	to	the	apical	medium	as	Fe-NTA	(1	M	ratio,	6	μCi/mL).	Transfer	of	iron	across	the	cell	layer	was	measured	by	taking	samples	from	the	basolateral	side,	replacing
the	sample	volume	with	fresh	buffer,	every	30	sec.
Following	incubation,	the	cells	were	washed	three	times	in	BSS	and	lysed	in	0.05	M	NaOH.	Cells	were	lysed	for	15	min	on	ice.	The	lysate	was	then	heated	for	30	min	at	90°	C	to	denature	the	DNA.	The	radioactivity	of	each
sample	(basolateral	media	and	cell	lysates)	was	measured	in	a	gamma	counter	(Wizard	3”	1480,	Automatic	gamma	counter,	Perkin	Elmer)	calibrated	against	standards	of	the	incubation	medium.
2.5	RT-qPCR
After	treatment,	cells	were	washed	with	PBS.	Total	RNA	was	isolated	from	trypsinised	cells	using	an	RNeasy	kit	(Qiagen	Cat	N°74104)	added	to	an	RNase-Free	DNase	set	(Qiagen	Cat	N°79254).	RNA	(200	ng)	was	reverse
transcribed	with	a	Taqman	reagent	kit	(Applied	Biosystems,	cat	N°4312704)	according	to	the	following	cycle:	25	°C	for	10	min,	37	°C	for	60	min	and	95	°C	for	5	min.	The	cDNA	was	amplified	with	Power	SYBR	Green	Master	mix
(Applied	Biosystems,	Life	Technologies,	cat	N°4309155).	Real	time	qRT–PCR	was	performed	using	Applied	Biosystem	7500	Fast	thermal	cycler	according	to	the	following	cycle:	95	°C	for	10	min,	1	repeat;	95	°C	for	15	seconds	and
60	°C	for	1	min,	40	repeats.	Specific	primers	were	designed	with	the	Primer	BLAST	tool	from	NCBI	and	checked	for	single	amplification	(Table	2).	DMT1	primers	were	designed	to	differentiate	isoforms	according	to	the	presence	of
IRE	(DMT1	+IRE	(exon1A	or	1B)),	the	absence	of	IRE	(DMT1	−IRE	(exon	1A	or	1B)),	the	presence	of	exon	1A	(DMT1	(±IRE)	exon1A),	or	the	presence	of	exon	1	B	(DMT1	(±IRE)	exon1B).
Table	2	Nucleotide	sequence	of	primers	used	to	determine	levels	of	the	genes	measured	in	this	paper.
alt-text:	Table	2
Gene	of	interest Type	of	sequence Nucleotide	sequence
DMT1(+IRE) Forward ACC	TTA	GAA	CTG	GAT	TAG	GGT
Reverse AAG	GAT	AAA	CTG	AGC	TCG	CCC
DMT1(-IRE) Forward AAA	TGT	AGG	TCA	GAG	ACC	CAC
Reverse AAT	CCC	AGA	GTC	CAA	GAC	ACA
DMT1(exon1A) Forward AGG	CAG	CTC	CAC	ACT	GTG	AAC
Reverse ACA	TCT	TCT	GTT	CAG	GAC	CCA
DMT1(exon1b) Forward TGG	CGC	TGG	CTC	CCG	GAA	TAT
Reverse GAA	TAT	GAT	TCT	TAC	CAG	CTC
18S Forward AGA	AAC	GGC	TAC	CAC	ATC	CCA
Reverse CAC	CAG	ACT	TGC	CCT	CCA
The	other	primers	were	purchased	from	Qiagen	(Quantitect	primers)	(Table	3).	Expression	data	were	normalized	using	Ct	values	of	the	internal	control	18S.	Fold	differences	were	calculated	using	the	ΔΔCt	method	[34].
Table	3	Product	number	and	company	of	purchase	of	commercially	available	primers.
alt-text:	Table	3
Gene	of	interest Company	of	purchase Catalogue	number
Ferritin	Light	(Hs_FTL_1_SG) Qiagen	(Quantitect	primers) QT00055860
Ferritin	Heavy	(Hs_FTH1_1_SG) Qiagen	(Quantitect	primers) QT00072681
Ferroportin	(Hs_SLC40A1_1_SG) Qiagen	(Quantitect	primers) QT00094843
Hepcidin	(Hs_HAMP_1_SG) Qiagen	(Quantitect	primers) QT00200522
Hephaestin	(Hs_HEPH_1_SG) Qiagen	(Quantitect	primers) QT00008106
2.6	Protein	expression	of	ferroportin	and	intracellular	and	extracellular	ferritin	heavy	chain	by	ELISA
After	differentiation,	cells	were	treated	overnight	with	various	concentrations	(0-–100%)	of	essential	and	non-essential	amino	acids.	The	medium	was	recovered	for	each	sample	to	measure	extracellular	levels	of	ferritin.	Cells
were	washed,	scraped	into	PBS	and	collected	by	centrifugation	for	3	min	at	3000xg.	The	cell	pellets	were	washed,	resuspended	in	PBS	and	ultra-sonicated	at	low	amplification	3	times	for	5	sec.	The	suspension	was	then	centrifuged	at
1500xg	for	10	min	at	4	°C	to	remove	cellular	debris.	The	supernatant	was	then	transferred	into	a	fresh	tube.	The	proteins	in	recovered	medium	were	concentrated	using	Microcon®	Centrifugal	Filter	Devices	(Merck	Millipore).
Before	using	the	concentrators,	bovine	serum	albumin	(Sigma	Aldrich,	BSA,	P5369)	(final	concentration	0.1	mg/mL)	was	added	to	the	samples	to	reduce	non-specific	binding.	Samples	were	concentrated	using	either	30	K	or
10	K	Microcon®	Centrifugal	Filter	Devices	(Merck	Millipore)	which	were	used	according	to	manufacturer’s	instructions.	The	volume	of	concentrated	medium	obtained	for	each	sample	was	recorded	in	order	to	normalise	the	results	of
the	ELISA.
Ferroportin	expression	levels	were	measured	using	a	sandwich	enzyme	immunoassay	kit	(SEC498Hu	96	tests,	Enzyme-linked	Immunosorbent	Assay	Kit	for	Ferroportin	(FPN),	Homo	sapiens	(human)	from	Cloud-Clone	Corp).
Intracellular	and	extracellular	ferritin	expression	levels	were	measured	using	a	sandwich	enzyme	immunoassay	kit	(SED021Hu	96	tests,	Enzyme-linked	Immunosorbent	Assay	Kit	for	Ferritin,	Heavy	Polypeptide	(FTH),	Homo	sapiens
(human)	from	Cloud-Clone	Corp).
After	bringing	samples	to	room	temperature,	ferritin	heavy	chain	extracellular	and	intracellular	levels	were	measured	using	manufacturer’s	instructions.	DNA	assays	were	performed	to	normalise	the	protein	levels,	and	data
were	then	expressed	as	percentage	of	the	control	(100%	amino	acids).
2.7	Statistical	analysis
All	experiments	were	repeated	three	times	and	values	are	expressed	as	means	±	S.E.M.	Values	were	normalized	by	the	DNA	content	of	each	insert	monolayer	and	expressed	as	%	of	control	(100%	amino	acids	at	30	min	for
transfer	experiments,	100%	amino	acids	for	RT-qPCR	and	protein	expression).
When	two	parameters	were	tested	(time	and	concentrations)	data	were	analysed	using	a	two-way	ANOVA	or	a	corresponding	non-parametric	test	when	equality	of	variances	was	not	verified.	When	only	one	parameter	varied,
statistical	significance	was	determined	by	one-way	ANOVA	or	corresponding	non-parametric	test	when	equality	of	variance	was	not	verified.
All	tests	were	performed	using	Graph-Pad	Prism	5	statistical	software	(http://www.graphpad.com/,	RRID:SCR_002798)	and	p˂	<	0.05	was	considered	as	significant.
3	Results
3.1	59Fe	transepithelial	transport	is	increased	by	both	essential	and	non-essential	amino	acid	deprivation
59Fe	across	 the	cells	monolayer	was	 linear	across	30	min	 incubation.	The	 transfer	was	 temperature	dependent,	as	would	be	expected	of	an	active	 transport	process.	Reducing	 the	concentration	of	either	essential	or	non-
essential	amino	acids	increased	transfer	across	the	cells	(p	<	0.0001	in	both	cases)	(Fig.	1A	and	B),	without	a	change	in	the	TEER	or	an	increase	in	Fe	levels	early	in	the	incubation	period,	as	might	be	expected	if	the	reduction	in	amino
acid	supply	were	increasing	passive	permeability	of	the	cell	layer.	Further,	phenol	red	levels	in	the	basolateral	medium	remained	undetectable	under	all	experimental	conditions	and	DNA	content	on	the	filters	was	not	altered	by	the
treatments	(Appendix	A,	Fig.	A1).
Reduction	of	essential	amino	acid	concentrations	did	not	affect	iron	content	of	the	cells	(one-way	ANOVA	p	=	0.72)	(Fig.	2A).	In	contrast,	depletion	of	non-essential	amino	acids	resulted	in	a	significant	increase	in	iron	content
(p	<	0.0001)	(Fig.	2B).
3.2	Gene	expression
The	expression	of	different	genes	involved	in	iron	metabolism	was	measured	following	essential	or	non-essential	amino	acid	depletion.
There	are	four	isoforms	of	DMT1,	with	exons	1A	or	1B,	both	either	with	or	without	an	iron	regulatory	element	(+IRE	or	−IRE	respectively).	As	explained	in	material	and	methods,	we	measured	the	presence	or	absence	of	one
feature	at	a	time.	When	measuring	the	presence	of	IRE,	the	isoform	expresses	exon1A	and	1B,	and	is	referred	as	+IRE	(exon1A	and	1B).	When	measuring	the	presence	of	exon1A,	the	isoform	expresses	either	IRE	or	not	and	is	referred
as	(±IRE)	exon1A.	Essential	amino	acid	depletion	resulted	in	a	decrease	in	expression	of	both	+IRE	(exon	1A	or	1B)	and	(±IRE)	exon1A	(respectively,	p	=	0.012	and	p	=	0.0007)	(Fig.	3A	and	B).	The	mRNA	levels	of	total	DMT1	showed
an	overall	significant	decrease	in	expression	(p	=	0.006)	(Fig.	3.C).	In	contrast	to	DMT1,	ferritin	heavy	chain	mRNA	levels	significantly	increased	with	essential	amino	acid	depletion	(p	=	0.01)	(Fig.	3D).
Fig.	1	Effect	of	changing	amino	acid	concentrations	on	iron	transport	through	a	Caco-2	cell	monolayer.	Caco-2	cells	were	incubated	overnight	with	differing	concentrations	of	(A)	essential	amino	acids	or	(B)	non-essential	amino	acids.	After	washing,	59Fe-
NTA	was	introduced	in	the	apical	side	and	59Fe	transported	through	the	monolayer	was	measured	from	the	basolateral	side	30	min	after	addition.	Values	were	normalized	to	the	DNA	content	of	each	insert	monolayer	and	expressed	as	%	of	control	(100%	AA
at	30	min).	Values	are	mean	±	S.E.M.,	n	=	6	per	treatment/time	point.	Statistical	significance	was	determined	by	a	two-way	ANOVA	followed	by	a	Bonferroni	post-hoc,	p<	<	0.0001	for	both	essential	and	non-essential	amino	acid	treatments.	ess	aa:	essential
amino	acids,	non	ess	aa:	non-essential	amino	acids,	aa:	amino	acids.
alt-text:	Fig.	1
Fig.	2	Effect	of	changing	amino	acid	concentrations	on	iron	levels	within	the	Caco-2	cell	monolayer.	Caco-2	cells	were	incubated	overnight	with	differing	concentrations	of	(A)	essential	amino	acids	or	(B)	non-essential	amino	acids.	After	washing,	59Fe-NTA
was	introduced	to	the	apical	side.	After	30	min,	cells	were	treated	as	described	in	Materials	and	Methods	and	59Fe	levels	within	the	cell	monolayer	were	determined.	Values	were	normalized	to	the	DNA	content	of	each	insert	and	expressed	as	%	control
(100%	AA).	Values	are	mean±	S.E.M.,	n	=	6.	Statistical	significance	was	determined	by	either	a	one	way	ANOVA	(p	=	0.0720)	(A)	or	a	non-parametric	Kruskall-Wallis	test	(p<	<	0.0001).	NTA:	nitrilotriacetate,	ess	aa:	essential	amino	acids,	non	ess	aa:	non-
essential	amino	acids.
alt-text:	Fig.	2
Non-essential	amino	acid	depletion	had	the	same	effect	as	essential	amino	acid	depletion	on	expression	on	DMT1	(±IRE)	exon1A	(p	=	0.006)	(Fig.	4A).	However,	it	did	not	affect	any	other	isoform.	In	contrast	to	the	effect	of
essential	amino	acid	depletion,	the	expression	levels	of	total	DMT1	were	not	changed	(data	not	shown).	Ferritin	heavy	chain	expression	and	hepcidin	also	increased	with	non-essential	amino	acid	depletion	(respectively	p	=	0.01	and
p	=	0.047)	(Fig.	4B	and	C).
Fig.	3	Effects	of	various	concentrations	of	essential	amino	acids	treatment	on	the	mRNA	levels	of	various	iron	metabolism	genes	in	differentiated	Caco-2	cells:	(A)	DMT1	+	IRE,	(B)	DMT1-exon1A,	(C)	Total	DMT1	(addition	of	relative	expression	of	DMT1	+IRE
and	−IRE)	and	(D)	Ferritin	Heavy	Chain.	Cells	were	grown	on	inserts	and	left	to	differentiate	until	the	TEER	reaches	240	Ω.	cm2.	Cells	were	then	treated	for	17	h	with	either	0,	10,	20,	30,	50,	70,	90	and	100%	essential	amino	acids	solutions.	Levels	of	mRNA
expression	were	measured	by	RT-qPCR	and	normalized	against	18S	as	housekeeper	and	expressed	as	percentage	of	control	(100%	amino	acids	solution).	Values	are	mean	±	S.E.M.,	n	=	12	or	18,	statistical	significance	was	determined	by	linear	regression,	(A)
p	=	0.012,	(B)	p	=	0.0007,	(C)	p	=	0.0058	and	(D)	p	=	0.01.	Linear	regression	was	used	to	explore	the	relationship	between	essential	amino	acid	deficiency	and	gene	expression.	The	true	relationship	between	these	variables	can	be	expected	to	be	more
complex	but	given	the	high	noise	in	the	measurements	and	the	small	sample	size	linear	regression	can	be	regarded	as	a	first	order	approximation	of	the	unknown	true	model,	that	allows	us	to	decide	whether	there	is	a	general	trend	of	protein	expression
increasing	or	decreasing	depending	on	amino	acid	deficiency.	TEER:	Transtrans-epithelial	electric	resistance,	DMT1:	divalent	metal	transporter	1,	IRE:	iron	responsive	element,	FTH:	ferritin	heavy	chain,	18S:	ribosomal	RNA	18S.	RT-qPCR:	quantitative	real
time	polymerase	chain	reaction,	ess	aa:	essential	amino	acids.
alt-text:	Fig.	3
We	hypothesized	that	the/increase	in	iron	transport	and/or	cell	content	were	due	to	an	increase	in	ferritin	excretion	from	the	cells	and/or	changed	expression	of	ferroportin,	which	is	regulated	by	ubiquitinylation	rather	than	at
mRNA	level	[12].	However,	protein	levels	of	ferritin	and	of	ferroportin	were	not	significantly	altered	by	any	of	the	treatments	(Appendix	A	Fig.	A2	and	Fig.	A3).
4	Discussion
In	this	paper,	we	have	shown	that	depletion	of	either	essential	or	non-essential	amino	acids	induces	an	increase	in	iron	transfer	from	the	apical	to	the	basolateral	side	of	a	Caco-2	cell	layer.	The	changes	cannot
be	accounted	for	by	alterations	in	the	cell	layer	permeability,	since	they	are	both	temperature	and	time	dependent,	there	is	no	alteration	in	the	transepithelial	electrical	resistance,	no	change	in	DNA	content	on	the
Fig.	4	Effects	of	various	concentrations	of	non-essential	amino	acids	treatment	on	the	mRNA	levels	of	various	iron	metabolism	genes	in	differentiated	Caco-2	cells:	(A)	DMT1	+	+IRE,	(B)	Ferritin	Heavy	Chain	and	(C)	Hepcidin.	Cells	were	grown	on	inserts
and	left	to	differentiate	until	the	TEER	reaches	240	Ω	cm2.	Cells	were	then	treated	for	17	h	with	either	0,	10,	20,	30,	50,	70,	90	and	100%	non-essential	amino	acids	solutions.	Levels	of	mRNA	expression	were	measured	by	RT-qPCR	and	normalized	against
18S	as	housekeeper	and	expressed	as	percentage	of	control	(100%	amino	acids	solution).	Values	are	mean	±	S.E.M.,	n	=	12	or	18,	statistical	significance	was	determined	by	linear	regression,	(A)	p	=	0.006,	(B)	p	=	0.01	and	(C)	p	=	0.0475.	Linear	regression
was	used	to	explore	the	relationship	between	non-essential	amino	acid	deficiency	and	gene	expression.	The	true	relationship	between	these	variables	can	be	expected	to	be	more	complex	but	given	the	high	noise	in	the	measurements	and	the	small	sample
size	linear	regression	can	be	regarded	as	a	first	order	approximation	of	the	unknown	true	model,	that	allows	us	to	decide	whether	there	is	a	general	trend	of	protein	expression	increasing	or	decreasing	depending	on	amino	acid	deficiency.	TEER:	Transtrans-
epithelial	electric	resistance,	DMT1:	divalent	metal	transporter	1,	FTH:	ferritin	heavy	chain,	FTL:	ferritin	light	chain,	18S:	ribosomal	RNA	18S,	RT-qPCR:	quantitative	real	time	polymerase	chain	reaction,	non	ess	aa:	non-essential	amino	acids.
alt-text:	Fig.	4
filters	and	no	significant	increase	in	marker	dye	concentration	in	the	basolateral	medium.	Consequently,	we	hypothesized	that	some	stage	in	the	iron	transfer	mechanism	had	to	be	modified	by	amino	acid	depletion.
We	measured	mRNA	levels	of	the	genes	of	iron	metabolism	known	to	be	regulated	at	this	level,	either	by	transcriptional	or	post-transcriptional	mechanisms.	We	also	measured	protein	levels	of	ferroportin,	since,	as	it
is	regulated	by	ubiquitinylation,	mRNA	is	not	necessarily	an	accurate	reflection	of	activity
The	first	stage	in	iron	transfer	is	the	uptake	into	the	cell	through	DMT1.	mRNA	levels	of	total	DMT1	decreased	as	a	consequence	of	depletion	of	essential,	but	not	non-essential,	amino	acids.	Both	treatments
reduced	the	expression	of	both	DMT1	(±IRE)	exons	1A	isoforms	(Figs.	3B	and	4A),	while	essential	amino	acid	deprivation	also	reduced	+IRE	(exon	1A	or	1B)	expression	(Fig.	3.A).	Given	that	DMT1	(+IRE/exon1A)	is
the	major	isoform	present	in	the	small	intestine,	it	seems	logical	that	alterations	in	exon1A	and	+IRE	isoforms	would	induce	changes	in	the	levels	of	total	DMT1	(Fig.	3C)	and	hence	DMT1	protein	levels,	since	the	two
correlate	well	in	gut	cells	[35,36].	If	DMT1	were	the	rate	limiting	step	for	transport,	then	a	decrease,	rather	than	an	increase	in	iron	transfer	would	be	predicted.	However,	results	from	different	studies	suggest	that
DMT1	is	not	the	limiting	step	in	iron	transport	in	the	brain	[37–40]	and	our	data	support	this	contention	in	the	gut.	Ferroportin	is	considered	to	be	the	limiting	step	for	iron	export	from	the	cell.	However,	the	increased
transport	of	iron	in	both	types	of	AA	depletion	cannot	be	explained	by	changes	in	ferroportin	expression,	which	remained	constant	in	our	study.
Non-essential	amino	acid	depletion	induced	an	increase	in	hepcidin	mRNA	levels.	However,	mRNA	levels	in	Caco-2	cells	are	very	low	and	it	is	not	clear	whether	protein	produced	by	these	cells	will	have	an
effect	on	iron	uptake.	Our	results	would	suggest	not,	since	an	increased	hepcidin	production	by	the	liver	is	associated	to	a	decrease,	rather	than	an	increase	in	iron	transfer.	Increased	levels	of	hepcidin	are	associated
with	inflammation	[41].	The	mRNA	up-regulation	of	hepcidin,	even	if	only	at	very	low	levels,	could	be	reflective	of	inflammation.	This	contrasts	with	previous	studies	reporting	that	amino	acid	starvation	is	associated
with	oxidative	stress	and	apoptosis,	which	in	turn	decreases	levels	of	hepcidin	[5,42].	It	should	be	noted,	however,	that	this	effect	occurs	in	liver	rather	than	gut	cells.	Interestingly,	glutamine,	a	non-essential	AA,	has
been	shown	to	decrease	inflammation	in	the	human	gut	and	the	lack	of	glutamine	increases	interleukin-8	production	in	Caco-2	cells	[43].	It	is	therefore	possible	that	the	lack	of	glutamine	in	our	model	had	a	pro-
inflammatory	effect	on	Caco-2,	which	in	turn	led	to	increased	hepcidin	production	[44].	However	the	changes	in	hepcidin	production	by	the	enterocyte	were	not	associated	with	changes	in	ferroportin	expression	and
its	biological	role	remains	to	be	established.
Expression	of	ferritin	heavy	chain	mRNA	was	increased	by	both	essential	and	non-essential	amino	acid	deprivation	(Figs.	2D	and	3B).	Ferritin	is	an	iron	storage	protein,	so	a	possible	mechanism	explaining	the
increased	iron	transport	with	amino	acid	depletion	could	be	the	excretion	of	ferritin	into	the	basolateral	side	of	the	cells.	Higher	expression	of	the	ferritin	heavy	chain	could	also	be	responsible	for	higher	iron	cell
content	and	would	explain	the	result	observed	with	non-essential	amino	acid	depletion.	Naturally,	the	increased	levels	of	iron	observed	inside	the	cells	could	also	increase	the	expression	of	ferritin	heavy	chain.	In	both
types	of	amino	acid	depletion,	ferritin	excretion	could	explain	the	increased	radioactive	levels	of	iron	found	in	the	basolateral	medium	without	observing	any	changes	in	the	mRNA	levels	of	ferroportin.	However,	the
protein	levels	of	ferritin	heavy	chain	(inside	the	cells,	and	total)	did	not	change	significantly	with	either	essential	or	non-essential	amino	acid	depletion.	The	regulation	of	ferritin	by	iron	is	complex.	Each	molecule	of
ferritin	can	hold	a	variable	amount	of	iron,	so	iron	content	could	change	markedly	without	changing	ferritin	protein	levels.	Similarly,	ferritin	turnover	is	altered	by	many	more	factors	than	just	iron	status.	At	this	stage,
the	lack	of	correlation	makes	it	difficult	to	draw	clear	conclusions	on	the	relationship	between	ferritin	levels	and	iron	transfer.	However,	the	simplest	conclusion	is	that	ferritin	is	not	involved	directly	in	the	increase	in
transfer.
At	this	stage,	therefore,	it	is	not	clear	what	underlies	the	increased	transfer	of	iron.	A	link	to	inflammation,	even	if	hepcidin	levels	are	increased	with	non-essential	amino	acid	depletion	seems	unlikely.	Rather,
inflammation	is	associated	with	increased	iron	storage	(which	in	this	case	occurs	only	in	non-essential	AA	depletion)	and	entrapment	of	iron	inside	the	cells,	together	with	a	decrease	in	the	expression	of	transferrin
and	the	internalization	and	degradation	of	ferroportin,	caused	by	hepcidin	up-regulation.
Very	little	is	known	about	the	mechanism	underpinning	the	movement	of	iron	from	the	apical	to	the	basolateral	side	of	the	gut	cell.	The	iron	inside	the	cell	is	thought	to	be	ferrous	iron	(Fe2+)	and	it	seems
unlikely	that	this	highly	reactive	and	toxic	form	of	iron	is	left	free	inside	the	cell.	Different	studies	have	suggested	the	importance	of	an	apotransferrin	cycle	in	the	transport	of	iron.	Moniya,	et	al.,	and	Nuñez,	et	al.
showed	that	adding	apotransferrin	to	the	basolateral	side	of	Caco-2	cells	significantly	increased	iron	transport	from	the	apical	to	the	basolateral	side	of	the	cells	[45].	They	also	showed	that	apotransferrin	was	stored
in	vesicles	above	the	nucleus	before	returning	to	the	basolateral	side	to	be	used	again	[46].	Another	study	revealed	that	iron	transfer	across	the	cell	layer	is	energy-dependent,	while	DMT1	is	only	a	proton-dependent
transporter.	However,	DMT1	also	depends	on	the	activity	of	the	Na+/K+	pump	which	is	an	ATPase,	and	therefore	energy-dependent	[47].	Interestingly,	transferrin	and	DMT1	have	been	detected	in	the	same	endosomes
as	well	[48].	Another	group	confirmed	the	involvement	of	apotransferrin	in	iron	transport	in	Caco-2	cells	but	also	suggested	that	up	to	50%	of	iron	transport	involved	vesicles.	They	used	inhibitors	of	various	aspects	of
vesicular	trafficking	such	as	nocodazole	and	5′-(4-fluorosulfonylbenzoyl)-adenosine,	and	showed	that	the	uptake	and	basolateral	transport	was	reduced	up	to	50%	depending	on	the	inhibitor	used	independently	of
apotransferrin	[49].	At	this	stage,	we	are	uncertain	whether	this	mechanism	is	correct,	though	it	does	seem	very	plausible,	and	would	also	help	to	explain	why	no	“chaperones”	of	iron	have	been	identified,	equivalent
to	those	clearly	identified	for	copper	[50,51].
In	summary,	therefore,	we	have	shown	for	the	first	time,	that	it	is	possible	for	iron	transfer	across	the	gut	layer	to	increase	without	concomitant	changes	in	the	genes	involved	in	the	transfer	process.	This	is	an
intriguing	outcome,	and	one	that	deserves	further	investigation.
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Appendix	A
Fig.	A1	Effect	of	changing	amino	acid	concentration	on	the	DNA	content	of	Caco-2.	Caco-2	cells	were	incubated	overnight	with	differing	concentrations	of	(A)	essential	amino	acids	or	(B)	non-essential	amino	acids.	After	washing,	59Fe-NTA	was	added	on	the
apical	side.	After	30	min,	cells	were	treated	as	described	in	Materials	and	Methods	and	DNA	levels	within	the	cell	monolayer	were	measured	(in	μgDNA/mL).	Values	were	expressed	as	percentage	of	the	control	(100%	amino	acids).	Values	are	mean	±	S.E.M.,
n	=	3,	statistical	significance	was	determined	by	a	one-way	ANOVA,	p	=	0.43	(EAA)	and	p	=	0.77	(NEAA).	Ess	aa:	essential	amino	acids,	non	ess	aa:	non-essential	amino	acids,	aa:	amino	acids,	DNA:	deoxyribonucleic	acid.
alt-text:	Fig.	A1
Fig.	A2	Effect	of	changing	concentrations	of	essential	(A)	and	non-essential	amino	acids	(B)	on	the	protein	expression	of	ferroportin	in	Caco-2	cells.	Cells	were	grown	as	described	in	Materials	and	Methods	until	the	TEER	reached	240	Ω	cm2.	Cells	were	then
incubated	overnight	with	different	concentrations	of	amino	acids.	After	washing,	cells	were	scraped	of	the	plates,	centrifuged	and	ultra-sonicated.	Ferroportin	protein	expression	was	measured	in	the	cell	lysates	by	ELISA.	Values	were	normalized	to	DNA
content	and	expressed	as	%	control	(100%	amino	acids).	Values	are	mean	±	S.E.M.,	n	=	6,	statistical	significance	was	determined	by	linear	regression,	p	=	0.19	(EAA)	and	p	=	0.24	(NEAA).	TEER:	Transtrans-epithelial	electric	resistance,	FPN:	ferroportin,	ess
aa:	essential	amino	acids,	non	ess	aa:	non-essential	amino	acids.
alt-text:	Fig.	A2
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